Raffaele Colombo, Director of Medicinal Chemistry at Zymeworks Inc., shared on X:
“INN Proposed List 135 just published.
Here are the newly assigned International Nonproprietary Names (INN) for ADCs, decoded! New drug-linker names: birsatecan, cilotecan, mipitecan, and ponetansine. Antibody names are getting so much easier to pronounce.
Enjoy!”
Other articles about ADCs on OncoDaily.